More than one in 10 cases of multiple sclerosis (MS) begin after age 50, with more rapid progression to disability and less exposure to and benefit […]

Stroke, Alzheimer’s disease (AD), and other neurological conditions are now the leading cause of health loss and disability around the world, affecting nearly half of the […]

Skipping meals, mood and anxiety disorders, as well as vaping and substance use, all raise the risk for frequent recurrent headaches in children and adolescents, new […]

WEST PALM BEACH, FLORIDA — An over-the-counter (OTC) antihistamine that had shown potential for treatment of multiple sclerosis (MS) in animal studies was linked to significant […]

WEST PALM BEACH, California — Aspirin and acetaminophen may offer an effective and inexpensive solution to exercise-induced heat sensitivity in relapsing-remitting multiple sclerosis (RRMS), results from […]

People with essential tremor (ET) have nearly three times increased risk of developing dementia compared with the general population, new research showed. In a prospective, longitudinal […]

TOPLINE: Obstructive sleep apnea (OSA) is associated with a significantly higher risk for stroke — regardless of continuous positive airway pressure (CPAP) device use — but […]

Treatment with the investigational monoclonal antibody drug batoclimab significantly improved symptoms in patients with antibody-positive generalized myasthenia gravis (MG), data from a new phase 3 study […]

The watchdog group Public Citizen is calling for the prompt removal of the amyotrophic lateral sclerosis (ALS) drug sodium phenylbutyrate/taurursodiol (Relyvrio) after it failed to meet […]